The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Quantile regression with cubic B-splines under monotonicity and convexity constraints using the Karlin-Studden SOCP formulation. The method is described in Abbes (2026) <doi:10.5281/zenodo.17427913>. This R implementation is intended for demonstration and prototyping; all B-spline and polynomial functions have been rewritten for consistency. A faster version written in 'Python' is available at <https://github.com/alexandreabbes/Constrained-Quantile-Regression-with-cubic-splines>.
| Version: | 0.1.0 |
| Depends: | R (≥ 3.5.0) |
| Imports: | CVXR |
| Suggests: | cobs, quantreg, pracma |
| Published: | 2026-06-23 |
| DOI: | 10.32614/CRAN.package.BsplineQuantReg |
| Author: | Alexandre Abbes [aut, cre] |
| Maintainer: | Alexandre Abbes <alexandre.abbes at proton.me> |
| BugReports: | https://github.com/alexandreabbes/BsplineQuantReg/issues |
| License: | GPL-3 |
| URL: | https://github.com/alexandreabbes/BsplineQuantReg, https://doi.org/10.5281/zenodo.17427913 |
| NeedsCompilation: | no |
| Citation: | BsplineQuantReg citation info |
| Materials: | README |
| CRAN checks: | BsplineQuantReg results |
| Reference manual: | BsplineQuantReg.html , BsplineQuantReg.pdf |
| Package source: | BsplineQuantReg_0.1.0.tar.gz |
| Windows binaries: | r-devel: BsplineQuantReg_0.1.0.zip, r-release: BsplineQuantReg_0.1.0.zip, r-oldrel: BsplineQuantReg_0.1.0.zip |
| macOS binaries: | r-release (arm64): BsplineQuantReg_0.1.0.tgz, r-oldrel (arm64): BsplineQuantReg_0.1.0.tgz, r-release (x86_64): BsplineQuantReg_0.1.0.tgz, r-oldrel (x86_64): BsplineQuantReg_0.1.0.tgz |
Please use the canonical form https://CRAN.R-project.org/package=BsplineQuantReg to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.